Tags

Type your tag names separated by a space and hit enter

Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment.
Ann Hematol. 1992 Aug; 65(2):96-102.AH

Abstract

Iron status was assessed by measuring serum (S-) ferritin and hemoglobin (Hb) in a population survey comprising 1359 nonpregnant Danish women, in age cohorts of 30, 40, 50, and 60 years; 809 were premenopausal and 550 postmenopausal. Median age for menarche was 14 years, for menopause (artificial and natural) 48 years. Premenopausal women had lower S-ferritin (median 37 micrograms/l) than postmenopausal women (median 71 micrograms/l; p less than 0.0001). Of the premenopausal women, 17.7% had S-ferritin less than 15 micrograms/l (i.e., depleted iron stores), and 23.1% S-ferritin of 15-30 micrograms/l (i.e., small iron stores). Corresponding figures in postmenopausal women were 3.3% and 10.3%. Hb values in premenopausal women were mean 137 +/- 10 (SD) g/l (8.5 +/- 0.6 mmol/l) vs. 140 +/- 10 g/l (8.7 +/- 0.6 mmol/l) in postmenopausal women (p less than 0.0001); 4.1% of pre- and 3.3% of postmenopausal women had values less than 121 g/l (7.5 mmol/l). Iron deficiency anemia (i.e., S-ferritin less than 15 micrograms/l and Hb less than 121 g/l) was found in 2.6% of pre- and 0.36% of postmenopausal women. Premenopausal multipara had lower S-ferritin than nulli- and unipara (p less than 0.04). The use of oral contraceptives had a marked influence on iron stores; premenopausal women taking the pill had higher S-ferritin and a lower frequency of depleted iron reserves than nonusers (p less than 0.01). Postmenopausal estrogen treatment had no influence on S-ferritin or Hb.

Authors+Show Affiliations

Milman N
Department of Medicine Y, Gentofte Hospital, Hellerup, Denmark.
Kirchhoff M
No affiliation info available
Jørgensen T
No affiliation info available

MeSH

AdolescentAdultAgingContraceptives, Oral, HormonalDenmarkEstrogen Replacement TherapyFemaleFerritinsHemoglobinsHumansIronMenopauseMenstruationMiddle AgedParity

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

1511065

Clinical Trial Links

Iron Status in Female Infertility and Recurrent Miscarriage

Citation

Milman, N, et al. "Iron Status Markers, Serum Ferritin and Hemoglobin in 1359 Danish Women in Relation to Menstruation, Hormonal Contraception, Parity, and Postmenopausal Hormone Treatment." Annals of Hematology, vol. 65, no. 2, 1992, pp. 96-102.
Milman N, Kirchhoff M, Jørgensen T. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Ann Hematol. 1992;65(2):96-102.
Milman, N., Kirchhoff, M., & Jørgensen, T. (1992). Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Annals of Hematology, 65(2), 96-102.
Milman N, Kirchhoff M, Jørgensen T. Iron Status Markers, Serum Ferritin and Hemoglobin in 1359 Danish Women in Relation to Menstruation, Hormonal Contraception, Parity, and Postmenopausal Hormone Treatment. Ann Hematol. 1992;65(2):96-102. PubMed PMID: 1511065.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. AU - Milman,N, AU - Kirchhoff,M, AU - Jørgensen,T, PY - 1992/8/1/pubmed PY - 1992/8/1/medline PY - 1992/8/1/entrez KW - Age Factors KW - Biology KW - Contraception KW - Contraceptive Agents KW - Contraceptive Agents, Female KW - Contraceptive Methods KW - Demographic Factors KW - Denmark KW - Developed Countries KW - Endocrine System KW - Estrogens KW - Europe KW - Examinations And Diagnoses KW - Family Planning KW - Fertility KW - Fertility Measurements KW - Hemic System KW - Hemoglobin Level--women KW - Hormones KW - Laboratory Examinations And Diagnoses KW - Menopause KW - Menstruation KW - Northern Europe KW - Oral Contraceptives KW - Parity KW - Physiology KW - Population KW - Population Characteristics KW - Population Dynamics KW - Reproduction KW - Research Report KW - Scandinavia KW - Serum Iron Level--women SP - 96 EP - 102 JF - Annals of hematology JO - Ann Hematol VL - 65 IS - 2 N2 - Iron status was assessed by measuring serum (S-) ferritin and hemoglobin (Hb) in a population survey comprising 1359 nonpregnant Danish women, in age cohorts of 30, 40, 50, and 60 years; 809 were premenopausal and 550 postmenopausal. Median age for menarche was 14 years, for menopause (artificial and natural) 48 years. Premenopausal women had lower S-ferritin (median 37 micrograms/l) than postmenopausal women (median 71 micrograms/l; p less than 0.0001). Of the premenopausal women, 17.7% had S-ferritin less than 15 micrograms/l (i.e., depleted iron stores), and 23.1% S-ferritin of 15-30 micrograms/l (i.e., small iron stores). Corresponding figures in postmenopausal women were 3.3% and 10.3%. Hb values in premenopausal women were mean 137 +/- 10 (SD) g/l (8.5 +/- 0.6 mmol/l) vs. 140 +/- 10 g/l (8.7 +/- 0.6 mmol/l) in postmenopausal women (p less than 0.0001); 4.1% of pre- and 3.3% of postmenopausal women had values less than 121 g/l (7.5 mmol/l). Iron deficiency anemia (i.e., S-ferritin less than 15 micrograms/l and Hb less than 121 g/l) was found in 2.6% of pre- and 0.36% of postmenopausal women. Premenopausal multipara had lower S-ferritin than nulli- and unipara (p less than 0.04). The use of oral contraceptives had a marked influence on iron stores; premenopausal women taking the pill had higher S-ferritin and a lower frequency of depleted iron reserves than nonusers (p less than 0.01). Postmenopausal estrogen treatment had no influence on S-ferritin or Hb. SN - 0939-5555 UR - https://www.unboundmedicine.com/medline/citation/1511065/Iron_status_markers_serum_ferritin_and_hemoglobin_in_1359_Danish_women_in_relation_to_menstruation_hormonal_contraception_parity_and_postmenopausal_hormone_treatment_ DB - PRIME DP - Unbound Medicine ER -